MarketFriction

Healthcare Global Enterprises Ltd

NSE HCG · BSE 539787 · Hospital
₹668.75 +0.41%
NSE close2026-10-01
52 week range513.30 - 796.68
Market cap₹10,505 Cr.
P/E218
IPO 2016 · +207% since Microcap 250 Price band 20% Delivery 61.6%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales487470495526554559585613647633652695
Expenses402391403435451470480505524524527573
Operating Profit8579929110288106108123110125122
OPM %17%17%19%17%18%16%18%18%19%17%19%18%
Other Income36991161083-10-1813
Interest272927343641444544454340
Depreciation434446475057585863616370
Profit before tax1811281928-3141220-6125
Tax %40%69%17%28%25%-335%50%50%-4%30%-223%34%
Net Profit11323142187621-8416
EPS in Rs0.920.391.440.821.220.470.500.321.09-0.630.150.92
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5847008299761,0921,0091,3951,6911,9082,2182,5382,627
Expenses4995957138649368871,1611,3941,5811,8352,0802,147
Operating Profit85105116112157122234297327384459480
OPM %15%15%14%11%14%12%17%18%17%17%18%18%
Other Income-210251010-72110152439-11-13
Interest3823427013811998104109155177171
Depreciation44577185148159158163174211244257
Profit before tax03527-33-119-229884568572740
Tax %-730%34%38%-7%5%-3%56%61%39%14%15%
Net Profit22317-31-125-221391841492333
EPS in Rs-0.162.442.23-2.66-11.36-14.583.651.993.273.010.921.53
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth16%20%14%14%
Compounded Profit Growth39%18%-1%30%
Stock Price CAGR12%24%26%10%
Return on Equity-1%4%4%3%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital708586878889125139139139139149
Reserves2103413474283892935727317216867831,183
Borrowings3493244204646581,3479779159011,2741,8371,735
Other Liabilities147294372461515518357433549601780853
Total Liabilities7761,0431,2251,4401,6502,2462,0312,2182,3112,7013,5403,920
Fixed Assets5285836858289701,6461,3821,5471,5531,7582,4422,462
CWIP4212114817415346302218832519
Investments0641153493426910101114
Other Assets2052753813854785205936417308501,0621,426
Total Assets7761,0431,2251,4401,6502,2462,0312,2182,3112,7013,5403,920
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity6073919898130121220252285317347
Cash from Investing Activity-79-204-210-283-238-101-171125-133-226-488-177
Cash from Financing Activity222168916184-58112-155-140-64-42241
Net Cash Flow285-29-24-56-3062190-22-5-213410
Free Cash Flow-20-137-101-158-90238515012610111059
CFO/OP87%99%93%88%121%100%68%104%92%101%91%83%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days454354575962675765566660
Inventory Days363240464535323133333332
Days Payable208264272274303234221199214216210185
Cash Conversion Cycle-127-188-178-171-200-136-121-112-116-127-111-93
Working Capital Days-65-96-112-74-110-102-26-43-40-70-91-61
ROCE %7%6%7%6%3%1%-1%5%8%9%9%8%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters71.30%71.29%71.28%71.26%71.23%71.22%71.22%62.46%63.78%63.77%64.21%64.21%
FIIs6.29%6.37%6.74%3.95%4.30%2.77%2.44%2.16%3.59%3.22%2.76%2.73%
DIIs7.94%8.46%8.52%10.89%11.64%12.94%12.48%13.22%18.36%18.30%18.91%19.20%
Public14.49%13.89%13.45%13.90%12.84%13.07%13.86%22.17%14.28%14.71%14.15%13.86%
No. of Shareholders27,32727,28927,19526,52929,67032,82045,39447,02846,97045,36647,64948,905

Fundamentals

Market Cap₹ 10,505 Cr.
Current Price₹ 704
Stock P/E218
Book Value₹ 89.2
ROCE8.30 %
ROE2.54 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)14%
Compounded Profit Growth (TTM)30%
Consolidated figures.
Valuation
Market capRs 9,985 Cr
Enterprise valueRs 11,179 Cr
P/E (TTM)438.30x
Price to book7.50x
Price to sales3.80x
EV / EBITDA23.90x
EV / EBIT52.98x
EV / sales4.25x
Price to cash flow28.77x
Earnings yield0.23%
P/E, 3-year average278.70x
P/B, 3-year average6.56x
P/E, 5-year average205.83x
P/B, 5-year average5.64x
Profitability
Operating margin (excl. other income)18.07%
Operating margin (incl. other income)17.63%
EBITDA margin17.80%
Pre-tax margin1.52%
Net profit margin0.87%
Net margin, latest quarter1.98%
ROE1.22%
ROCE6.98%
ROA0.37%
ROE, 3-year average4.00%
ROCE, 3-year average8.28%
ROA, 3-year average1.24%
ROE, 5-year average4.45%
ROCE, 5-year average8.78%
ROA, 5-year average1.51%
ROIC (approx.)7.07%
Tax rate15.38%
Other income / net worth-0.84%
Growth
Sales growth (latest year)14.44%
Profit growth (latest year)-69.02%
Sales CAGR, 3 years14.49%
Sales CAGR, 5 years20.26%
Profit CAGR, 3 years-22.32%
Sales growth QoQ6.56%
Profit growth QoQ534.56%
Sales growth YoY (latest quarter)13.36%
Profit growth YoY (latest quarter)189.89%
Per share
EPS (TTM)Rs 1.53
EPS (latest year)Rs 0.92
EPS (latest quarter)Rs 0.92
EPS, 3-year averageRs 2.52
EPS, 5-year averageRs 2.71
Book value per shareRs 89.21
Sales per shareRs 175.98
Cash flow per shareRs 23.25
Free cash flow per shareRs 3.95
Efficiency
Asset turnover0.65x
Fixed asset turnover1.03x
Inventory turnover24.01x
Inventory days15 days
Debtor days60 days
Debtors turnover6.03x
Creditor days185 days
Cash conversion cycle-93 days
Working capital days-61 days
Leverage
Total debtRs 1,735 Cr
Cash and bankRs 541 Cr
Net debtRs 1,194 Cr
Debt to equity1.30x
Net debt / EBITDA2.55x
Interest coverage1.23x
Current ratio (filing 2026-03-31)1.09x
Quick ratio (filing 2026-03-31)1.03x
Trade payables (filing 2026-03-31)Rs 351 Cr
Owners' fund to total sources33.98%
Debt to assets44.27%
Cash flow
Cash from Operating Activity (latest year)Rs 347 Cr
Cash from Investing Activity (latest year)Rs -177 Cr
Cash from Financing Activity (latest year)Rs 241 Cr
Net Cash Flow (latest year)Rs 410 Cr
Free cash flow (latest year)Rs 59 Cr
FCFE (approx.: FCF + change in debt)Rs -43 Cr
Cash from ops / profit, 5 years8.36x
Sales to cash flow7.31x
Statement figures
Net sales (TTM)Rs 2,627 Cr
Net sales (latest year)Rs 2,538 Cr
Sales (latest quarter)Rs 695 Cr
Operating profit excl. other income (latest year)Rs 459 Cr
Operating profit (latest quarter)Rs 122 Cr
Other income (TTM)Rs -13 Cr
EBITDA (TTM)Rs 468 Cr
PBDT (TTM)Rs 297 Cr
Profit before tax (TTM)Rs 40 Cr
Tax (latest year)Rs 4 Cr
Net profit (TTM)Rs 23 Cr
Net profit (latest year)Rs 14 Cr
Net profit (latest quarter)Rs 14 Cr
Depreciation (TTM)Rs 257 Cr
Depreciation (latest quarter)Rs 70 Cr
Interest (TTM)Rs 171 Cr
Cost of goods sold (latest year)Rs 1,436 Cr
Total expenditure (latest year)Rs 2,080 Cr
Total income (latest year)Rs 2,527 Cr
Share capitalRs 149 Cr
ReservesRs 1,183 Cr
Shareholders' fundsRs 1,332 Cr
Total assetsRs 3,920 Cr
Net blockRs 2,462 Cr
Capital work in progressRs 19 Cr
InvestmentsRs 14 Cr
ReceivablesRs 421 Cr
InventoryRs 60 Cr
Other liabilitiesRs 853 Cr
Shares outstanding (crore)14.93
Ownership
Promoter holding64.21% (+1.75 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/B 7.50 is at the 66th percentile (median 6.34).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodHCGNifty 50Difference
1 week-4.6%-2.8% -1.8 pts
1 month-5.1%-6.8% +1.7 pts
3 months+2.1%-7.6% +9.7 pts
6 months+27.3%+0.4% +26.9 pts
1 year+2.1%-9.9% +12.0 pts
2 years+62.0%-13.6% +75.6 pts
3 years+87.0%+14.2% +72.8 pts
5 years+172.5%+27.9% +144.6 pts
43 mutual fund schemes hold about ₹2,020 Cr. Over three months 35 bought more and 3 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Nippon India Small Cap Fund0.41%342 +9%
Nippon India ELSS Tax Saver Fund1.85%272 +16%
Axis Small Cap Fund0.76%240 +7%
Franklin India Small Cap Fund0.88%130 +100%
Axis Flexi Cap Fund0.83%116 +9%
Axis Flexi Cap Fund0.83%112 +9%
Tata India Pharma & Healthcare Fund6.30%97 +12%
Tata Focused Fund4.21%74 +15%
SBI Healthcare Opp Fund1.26%73 +100%
Tata Aggressive Hybrid Fund1.80%73 +41%
Motilal Oswal Business Cycle Fund4.29%66 +1%
Motilal Oswal Consumption Fund5.27%62 +2%
Axis Multicap Fund0.50%54 +100%
Tata ELSS-Tax Saver Fund1.11%53 +11%
Tata Flexi Cap Fund0.95%35 +35%
Tata Multi Asset Allocation Fund0.60%32 +100%
Nippon India Retirement Fund-Wealth Creation0.97%31 +13%
Helios Small Cap Fund1.39%20 -2%
Tata India Innovation Fund1.29%17 +18%
Axis Business Cycles Fund0.76%17 +10%
Bandhan Mid Cap Fund0.61%16 +3%
Tata Multicap Fund0.41%15 +100%
Axis Value Fund0.63%12 +51%
Tata Dividend Yield Fund1.03%12 +100%
Motilal Oswal Nifty Microcap 250 Index Fund0.41%10 +7%

Red flags

F-score 6 of 8
explainLow interest cover Interest cover 1.2x in 2026
lookAuditor change Auditor change 2025-12-01: Healthcare Global Enterprises Limited has informed the Exchange regarding Change in Auditors of the company.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹695 Cr +13.4% vs Jun 2025. Net profit ₹16 Cr +166.7%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Apollo Hospitals Enterprise Ltd124,50359.217.4 %
Manipal Health Enterprises Ltd98,35711112.1 %
Max Healthcare Institute Ltd95,58963.814.7 %
Aster DM Quality Care Ltd63,97617711.6 %
Fortis Healthcare Ltd62,05858.213.4 %
Global Health Ltd38,04866.417.4 %
Narayana Hrudayalaya Ltd36,57942.415.5 %
Krishna Institute of Medical Sciences Ltd32,3361559.50 %
Dr Agarwals Health Care Ltd15,70110610.9 %
Rainbow Childrens Medicare Ltd13,89248.517.4 %
Park Medi World Ltd11,89842.819.5 %
Yatharth Hospital & Trauma Care Services Ltd10,67658.912.9 %
Jupiter Life Line Hospitals Ltd8,59144.914.8 %
Kovai Medical Center & Hospital Ltd6,57925.722.6 %
Artemis Medicare Services Ltd5,81850.414.5 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-03-02Rights 1:17 @ Premium Rs 502/-
2022-09-22Annual General Meeting
2021-09-23 Annual General Meeting
2019-09-19 Annual General Meeting
2018-09-19 Annual General Meeting
2017-08-03 Annual General Meeting
2016-09-22 Annual General Meeting
DateTypeWhat it says
2026-09-18Shareholder meetingVoting results.
2026-09-18Shareholder meetingProceedings of Annual General Meeting held on September 18, 2026
2026-09-17Concall / analyst meetSchedule of meet
2026-09-16Concall / analyst meetIntimation of Schedule of meeting with Institutional investors at Mumbai.
2026-09-09ESOP grantGrant of Employee Stock Options under HealthCare Global Enterprises Limited- Employee Stock Option Scheme, 2026
2026-08-28General UpdatesLetter to Members of the Company containing weblink and path of Integrated Annual Report for the Financial Year 2025-26.
2026-08-27Shareholder meetingNotice of Annual General Meeting to be held on September 18, 2026 and Annual Report for FY 2025-26
2026-08-27UpdatesBusiness Responsibility and Sustainability Report for FY 2026.
2026-08-10Concall / analyst meetTranscript of the Earnings Call held on August 07, 2026 to discuss the Unaudited Financial Results of the Company.
2026-08-07Concall / analyst meetSchedule of Group Investor meeting hosted by Ambit Capital to be held on August 12, 2026 in Bangalore.
2026-08-07Concall / analyst meetLink of Recording
2026-08-06Press ReleaseA press release dated August 06, 2026, titled "Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30,...
2026-08-06Investor PresentationInvestor Presentation
2026-08-06Monitoring Agency ReportPursuant to the Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 82(4) of SEBI (Issue...
2026-08-06Statement of deviation(s) orStatement of deviation(s) or variation(s) under Reg. 32
2026-08-06AppointmentRe-appointment of M/s. Rao Murthy & Associates, Cost Accountants as Cost Auditor of the company for FY 2026-27.
2026-08-06General UpdatesBoard approval for further investment of up to INR 16 Crore in HCG Rajkot Hospitals LLP, a wholly owned subsidiary of the Company.
2026-08-06Board meeting outcomeHealthcare Global Enterprises Limited has submitted to the Exchange, the financial results for the quarter ended Jun 30, 2026.
2026-08-04Memorandum of Understanding/Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI Listing Regulations ), we would like ...
2026-07-27Concall / analyst meetSchedule of meet
2026-07-09Shareholder meetingVoting results.
2026-06-29General UpdatesFurther to the intimation dated May 19, 2026, with respect to the approval of the Board of Directors of Company granted on May 19, 2026, for the execu...
2026-06-17Regulatory actionPursuant to Regulation 30 of the SEBI Listing Regulations read with sub-para 20 of Para A of Part A of Schedule III thereof, the Directorate General o...
2026-06-16Disclosure under SEBI TakeovHealthcare Global Enterprises Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board o...
2026-06-15Disclosure under SEBI TakeovHector Asia Holdings II Pte. Ltd. has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of In...
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd (HCG) has a market capitalisation of Rs 10,505 Cr. at the 2026-10-01 close.

What is the P/E ratio of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd trades at a P/E of 218 on trailing twelve-month profit, at the 2026-10-01 close.

What were Healthcare Global Enterprises Ltd's latest quarterly results?

In the Jun 2026 quarter, Healthcare Global Enterprises Ltd sales was Rs 695 Cr (+13.4% vs Jun 2025) and net profit was Rs 16 Cr.

What is the 52-week high and low of Healthcare Global Enterprises Ltd?

The 52-week high is Rs 796.68 and the 52-week low is Rs 513.30.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03